The Mel Robbins PodcastThe Ultimate Guide to Women’s Sexual Health, Hormone Replacement Therapy (HRT) & Menopause
At a glance
WHAT IT’S REALLY ABOUT
Women’s sexual health decoded: GSM, vaginal estrogen, HRT, testosterone advocacy
- Women’s sexual and urinary health complaints are frequently dismissed because many clinicians are not trained in sexual medicine anatomy, diagnosis, or modern hormone therapies beyond reproduction-focused gynecology.
- Dr. Rubin explains Genitourinary Syndrome of Menopause (GSM)—and similar low-estrogen states from breastfeeding, birth control, or cancer endocrine therapy—as a root cause of dryness, painful sex, urgency/frequency, leakage, and recurrent UTIs.
- Microdosed vaginal hormones (especially vaginal estrogen; sometimes vaginal DHEA) can restore pH/microbiome and tissue integrity, cutting recurrent UTI risk by more than half while also improving comfort and sexual function.
- Systemic HRT often does not adequately treat local vulvovaginal/bladder symptoms, so many patients need “local therapy” even if they already use an estrogen patch and progesterone.
- The episode details how fear from the 2002 Women’s Health Initiative media coverage and FDA boxed warnings suppressed care for decades, and highlights recent guideline/label changes plus a framework (“four buckets”) for individualized hormone decision-making.
IDEAS WORTH REMEMBERING
5 ideasRecurrent UTIs are often a hormone-and-microbiome problem, not just a “sex problem.”
Dr. Rubin links hormonal shifts (birth control, breastfeeding, perimenopause/menopause, breast-cancer endocrine therapy) to rising vaginal/bladder pH and dysbiosis that predispose to infections and UTI-like symptoms.
Microdosed vaginal estrogen is a cornerstone preventive therapy for many women with urinary and vaginal symptoms.
She states vaginal hormones can reduce recurrent UTIs by more than half by restoring tissue health and microbiome, and may improve urgency, frequency, irritation, and painful sex.
Systemic HRT frequently doesn’t resolve local genitourinary symptoms—local therapy may still be needed.
Even women using estrogen patches and progesterone may require vaginal estrogen/DHEA because low-dose local treatment targets the vulva/vagina/urethra directly where symptoms arise.
Vaginal estrogen is presented as low-risk and low-cost compared with repeated antibiotics.
The episode emphasizes minimal systemic absorption (levels remain near menopausal baseline) and highlights accessible options like generic estradiol cream (described as roughly $7/month) alongside tablets and a 3‑month ring.
Breastfeeding can mimic menopause (GSL), and vaginal hormones can be appropriate then too.
Rubin describes Genitourinary Syndrome of Lactation as a low-estrogen state with GSM-like symptoms and argues vaginal hormones are underoffered despite being safe and not affecting milk supply.
WORDS WORTH SAVING
5 quotes“Using vaginal hormones prevent urinary tract infections by more than half.”
— Dr. Rachel Rubin
“The two dirtiest words in the English language are vagina and estrogen.”
— Dr. Rachel Rubin
“Your boxed label tried to kill my mother.”
— Dr. Rachel Rubin
“Menopause is a castration event, where your hormones just turn off like a light bulb.”
— Dr. Rachel Rubin
“Sex should not be painful, and you deserve a diagnosis.”
— Dr. Rachel Rubin
High quality AI-generated summary created from speaker-labeled transcript.
Get more out of YouTube videos.
High quality summaries for YouTube videos. Accurate transcripts to search & find moments. Powered by ChatGPT & Claude AI.
Add to Chrome